Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis
Fitzpatrick, Meagan C
Zimmer, Charlotte F
Moghadas, Seyed M
Singer, Burton H
Galvani, Alison P
JournalProceedings of the National Academy of Sciences of the United States of America
PublisherNational Academy of Sciences of the United States of America
MetadataShow full item record
AbstractQuantification of asymptomatic infections is fundamental for effective public health responses to the COVID-19 pandemic. Discrepancies regarding the extent of asymptomaticity have arisen from inconsistent terminology as well as conflation of index and secondary cases which biases toward lower asymptomaticity. We searched PubMed, Embase, Web of Science, and World Health Organization Global Research Database on COVID-19 between January 1, 2020 and April 2, 2021 to identify studies that reported silent infections at the time of testing, whether presymptomatic or asymptomatic. Index cases were removed to minimize representational bias that would result in overestimation of symptomaticity. By analyzing over 350 studies, we estimate that the percentage of infections that never developed clinical symptoms, and thus were truly asymptomatic, was 35.1% (95% CI: 30.7 to 39.9%). At the time of testing, 42.8% (95% prediction interval: 5.2 to 91.1%) of cases exhibited no symptoms, a group comprising both asymptomatic and presymptomatic infections. Asymptomaticity was significantly lower among the elderly, at 19.7% (95% CI: 12.7 to 29.4%) compared with children at 46.7% (95% CI: 32.0 to 62.0%). We also found that cases with comorbidities had significantly lower asymptomaticity compared to cases with no underlying medical conditions. Without proactive policies to detect asymptomatic infections, such as rapid contact tracing, prolonged efforts for pandemic control may be needed even in the presence of vaccination.
Rights/TermsCopyright © 2021 the Author(s). Published by PNAS.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16383
- Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
- Authors: Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, Salanti G, Low N
- Issue date: 2020 Sep
- Universal screening for SARS-CoV-2 infection: a rapid review.
- Authors: Viswanathan M, Kahwati L, Jahn B, Giger K, Dobrescu AI, Hill C, Klerings I, Meixner J, Persad E, Teufer B, Gartlehner G
- Issue date: 2020 Sep 15
- Role of presymptomatic transmission of COVID-19: evidence from Beijing, China.
- Authors: Zhang Y, Muscatello D, Tian Y, Chen Y, Li S, Duan W, Ma C, Sun Y, Wu S, Ge L, Yang P, Jia L, Wang Q, MacIntyre CR
- Issue date: 2021 Jan
- Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis.
- Authors: Alene M, Yismaw L, Assemie MA, Ketema DB, Mengist B, Kassie B, Birhan TY
- Issue date: 2021
- Ratio of asymptomatic COVID-19 cases among ascertained SARS-CoV-2 infections in different regions and population groups in 2020: a systematic review and meta-analysis including 130 123 infections from 241 studies.
- Authors: Chen X, Huang Z, Wang J, Zhao S, Wong MC, Chong KC, He D, Li J
- Issue date: 2021 Dec 7